Study S000410

A Real-world, Observational Study of GLP-1 Therapy Added to Basal Insulin in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02895672
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 150
Start: 2016-08
Primary completion: 2016-11
Lead sponsor: Albany College of Pharmacy and Health Sciences
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:GLP-1 therapy
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

A1C [12 months]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0016179	A real-world, observational study of weekly exenatide added to basal insulin in patients with type 2 diabetes mellitus (NCT02895672). Stryker MD, Endocrinology, diabetes & metabolism	2018	Nonrandomized study	PMID 30815541 DOI	cites ClinicalTrials.gov:NCT02895672
R0039625	Abstract #200 A Real-World; Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus (NCT02895672) Matthew Stryker, Endocrine Practice	2018	Nonrandomized study	DOI	cites ClinicalTrials.gov:NCT02895672